GoodCorporation has worked for leading pharmaceutical firms in the UK with significant operations in the US and Western Europe. We have conducted assessments against the GoodCorporation Standard as well as anti-bribery and corruption assessments.
To provide a global perspective on the effectiveness of anti-bribery and ethics programmes we have conducted a number of assessments in overseas subsidiaries, so have an in depth understanding of the ethics and compliance risks of operating in some of the world’s more challenging markets.
Transparency in the relationship between healthcare professionals and pharmaceutical companies has dominated this sector for some time. We have been working with our clients to help them formulate best practice in responding to the current disclosure requirements.
Our ethics and compliance work has also involved the development of training programmes tailored to the needs of this sector.
“In 2006 Shire, seeking to raise its performance to the next level, hired GoodCorporation to e-survey selected stakeholder groups, both within and outside of Shire. The goal…is to qualify as a GoodCorporation which reflects not just good corporate responsibility policies are in place, but that stakeholders perceive those policies to be consistently enacted.” Shire Dynamics.
“GoodCorporation has provided us with a means of measuring and benchmarking our corporate responsibility performance based on stakeholder feedback that is accurate and commercially useful to the company.” Acambis
Our clients in this sector have included: Hikma, Shire, Acambis and the pharmaceuticals division of a worldwide food manufacturer.